IE55228B1 - Tricyclic compounds,preparation,and use - Google Patents

Tricyclic compounds,preparation,and use

Info

Publication number
IE55228B1
IE55228B1 IE949/83A IE94983A IE55228B1 IE 55228 B1 IE55228 B1 IE 55228B1 IE 949/83 A IE949/83 A IE 949/83A IE 94983 A IE94983 A IE 94983A IE 55228 B1 IE55228 B1 IE 55228B1
Authority
IE
Ireland
Prior art keywords
formula
compound
group
acid
acceptable salt
Prior art date
Application number
IE949/83A
Other languages
English (en)
Other versions
IE830949L (en
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Publication of IE830949L publication Critical patent/IE830949L/xx
Publication of IE55228B1 publication Critical patent/IE55228B1/en

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/04—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings directly linked by a ring-member-to-ring-member bond
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00—Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C65/00—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
    • C07C65/21—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups
    • C07C65/24—Compounds having carboxyl groups bound to carbon atoms of six—membered aromatic rings and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups containing ether groups, groups, groups, or groups polycyclic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/78—Ring systems having three or more relevant rings
    • C07D311/80—Dibenzopyrans; Hydrogenated dibenzopyrans
    • C07D311/82—Xanthenes
    • C07D311/84—Xanthenes with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 9
    • C07D311/86—Oxygen atoms, e.g. xanthones

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
IE949/83A 1982-04-27 1983-04-26 Tricyclic compounds,preparation,and use IE55228B1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB8212139 1982-04-27
GB8230055 1982-10-21

Publications (2)

Publication Number Publication Date
IE830949L IE830949L (en) 1983-10-27
IE55228B1 true IE55228B1 (en) 1990-07-04

Family

ID=26282657

Family Applications (1)

Application Number Title Priority Date Filing Date
IE949/83A IE55228B1 (en) 1982-04-27 1983-04-26 Tricyclic compounds,preparation,and use

Country Status (11)

Country Link
US (1) US4902701A (enExample)
EP (1) EP0093381B1 (enExample)
AU (1) AU566167B2 (enExample)
CA (1) CA1222516A (enExample)
DE (1) DE3364674D1 (enExample)
DK (1) DK185283A (enExample)
FI (1) FI82832C (enExample)
GR (1) GR78142B (enExample)
IE (1) IE55228B1 (enExample)
IL (1) IL68498A (enExample)
NZ (1) NZ204003A (enExample)

Families Citing this family (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB8309260D0 (en) * 1983-04-06 1983-05-11 Erba Farmitalia Condensed benzopyrone derivatives
GB8328494D0 (en) * 1983-10-25 1983-11-23 Wellcome Found Liquid containment systems
US4861795A (en) * 1988-06-23 1989-08-29 Rorer Pharmaceutical Corporation Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
US4849416A (en) * 1988-07-25 1989-07-18 Rorer Pharmaceutical Corporation Treatment of conditions requiring enhanced oxygen availability to mammalian tissues
US4996230A (en) * 1990-02-16 1991-02-26 Eli Lilly And Company Leukotriene antagonists
IT1261662B (it) * 1992-09-07 1996-05-28 Inverni Della Beffa Spa Derivati xantonici, loro preparazione ed attivita'
US5624794A (en) * 1995-06-05 1997-04-29 The Regents Of The University Of California Method for extending the useful shelf-life of refrigerated red blood cells by flushing with inert gas
US5977077A (en) * 1995-08-28 1999-11-02 Interlab Corporation Xanthone analogs for the treatment of infectious diseases
EP0795554A3 (en) * 1996-03-05 1998-01-28 Takeda Chemical Industries, Ltd. (Oxo-)xanthene derivatives, their preparation and their use as immunomodulators
US6355153B1 (en) * 1999-09-17 2002-03-12 Nutool, Inc. Chip interconnect and packaging deposition methods and structures
US7506438B1 (en) * 2000-11-14 2009-03-24 Freescale Semiconductor, Inc. Low profile integrated module interconnects and method of fabrication
US8828226B2 (en) 2003-03-01 2014-09-09 The Trustees Of Boston University System for assessing the efficacy of stored red blood cells using microvascular networks
US9199016B2 (en) 2009-10-12 2015-12-01 New Health Sciences, Inc. System for extended storage of red blood cells and methods of use
US12089589B2 (en) 2009-10-12 2024-09-17 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
NZ622456A (en) 2009-10-12 2015-09-25 New Health Sciences Inc Blood storage bag system and depletion devices with oxygen and carbon dioxide depletion capabilities
CA2781874A1 (en) 2009-10-12 2011-04-21 New Health Sciences, Inc. Oxygen depletion devices and methods for removing oxygen from red blood cells
US11284616B2 (en) 2010-05-05 2022-03-29 Hemanext Inc. Irradiation of red blood cells and anaerobic storage
EP4091645A1 (en) 2010-08-25 2022-11-23 Hemanext Inc. Method for enhancing red blood cell quality and survival during storage
WO2012061731A1 (en) 2010-11-05 2012-05-10 New Health Sciences Irradiation of red blood cells and anaerobic storage
US9067004B2 (en) 2011-03-28 2015-06-30 New Health Sciences, Inc. Method and system for removing oxygen and carbon dioxide during red cell blood processing using an inert carrier gas and manifold assembly
EP3061509B1 (en) 2011-08-10 2019-05-22 New Health Sciences, Inc. Integrated leukocyte, oxygen and/or co2 depletion, and plasma separation filter device
CA2902061C (en) 2013-02-28 2023-08-08 New Health Sciences, Inc. Gas depletion and gas addition devices for blood treatment
IL299978B2 (en) 2015-03-10 2024-08-01 Hemanext Inc Single-use oxygen reduction kits, devices and methods for their use
EP3285711A4 (en) 2015-04-23 2018-11-07 New Health Sciences, Inc. Anaerobic blood storage containers
EP4623991A3 (en) 2015-05-18 2025-12-17 Hemanext Inc. Methods for the storage of whole blood, and compositions thereof
EP3463466B1 (en) 2016-05-27 2022-02-16 Hemanext Inc. Anaerobic blood storage and pathogen inactivation method

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2783246A (en) * 1955-05-02 1957-02-26 Allied Chem & Dye Corp Manufacture of xanthene
BE759292A (fr) * 1969-11-27 1971-05-24 Allen & Hanburys Ltd Derives de xanthone, leur preparation et leur emploi
US4061768A (en) * 1971-09-08 1977-12-06 Burroughs Wellcome Co. Certain cyclic carbonyl compounds used in the prophylaxis of allergic conditions
AU478775B2 (en) * 1974-09-13 1974-12-12 Syntex Gu. S. A. ) Inc Novel substituted xanthone carboxylic acid compounds

Also Published As

Publication number Publication date
DK185283D0 (da) 1983-04-26
FI831420L (fi) 1983-10-28
GR78142B (enExample) 1984-09-26
IL68498A (en) 1986-09-30
DK185283A (da) 1983-10-28
EP0093381A1 (en) 1983-11-09
AU1392483A (en) 1983-11-03
CA1222516A (en) 1987-06-02
FI82832C (fi) 1991-04-25
AU566167B2 (en) 1987-10-08
EP0093381B1 (en) 1986-07-23
FI831420A0 (fi) 1983-04-26
DE3364674D1 (en) 1986-08-28
FI82832B (fi) 1991-01-15
IE830949L (en) 1983-10-27
IL68498A0 (en) 1983-07-31
NZ204003A (en) 1986-05-09
US4902701A (en) 1990-02-20

Similar Documents

Publication Publication Date Title
EP0093381B1 (en) Tricyclic compounds, preparation, use and intermediates
US4410537A (en) Pharmaceutical ethers
JPS60246375A (ja) ピリダジノン、その製法並びに該化合物を含有する気管支疾患治療剤
US3905989A (en) (Tetrazolyl)thioxanthone-10,10-dioxides
JPS63222161A (ja) 抗アレルギーおよび抗炎症剤として使用される新規なナフタレン誘導体
US4626432A (en) Storage of red blood cells
CN116947799A (zh) 酚类化合物、其制备方法及其在医药上的应用
JPS58194879A (ja) 三環式化合物
JPH0352874A (ja) 置換ベンゾニトリル
RU2117665C1 (ru) Производные 3-алкилокси-, арилокси- или арилалкилокси-бензо(b)тиофен-2-карбоксамида, их фармацевтически приемлемые соли и фармацевтическая композиция с активностью, ингибирующей адгезию лейкоцитов к васкулярному эндотелию
JPS6043351B2 (ja) 老人医学的薬剤の製法
IL28179A (en) Antibiotic composition containing cephalosporin derivatives and new cephalosporin derivatives
CA1229304A (en) Tricyclic compounds and their use
US4025635A (en) Cyclic sulphur compounds
US3890348A (en) Indole-1 and indoline-1-carboxamides and thiocarboxamides
Bray et al. The fate of certain organic acids and amides in the rabbit. 13. Chloro-and fluoro-benzoic acids and amides
CN109627198B (zh) 一种2-丙酮基硒基苯甲酰胺类化合物及其制备方法与应用
JPS5867618A (ja) １―アザキサントンからなる医薬
JPH04225956A (ja) 置換インドール
US3984534A (en) Tetrazolyl anthraquinones for inhibiting the release of spasmogen mediators
US4103015A (en) Antiallergic cyclic sulphur compounds
FI82833B (fi) Disubstituerade xanten- och xantonderivat och anvaendning av dessa foer uppraetthaollande av syretillfoerselfoermaogan hos upplagrade humaneretrocyter och foerlaengning av den anvaendbara upplagringstiden foer dessa.
CN116947832B (zh) 一种川芎嗪衍生物、其制备方法及医药用途
US3840662A (en) Method of treating atherosclerosis using 4-hydroxymethyl-1-keto-1,2-dihydrophthalazine or acid salts thereof
US4012499A (en) Cyclic sulphur compounds